Do note that the discount is valid only till stock lasts and some of the dealers, including those in Delhi, Chennai, and Pune ...

Recent Exact Sciences Corporation financials show accelerating revenue growth and stable margins, despite ongoing investments in screening and MRD. While EXAS maintains leadership in stool-based CRC ...

Recent patent disclosures indicate that BYD has strengthened its work on variable-flux permanent-magnet synchronous motor technology, with four filings published by the China National Intellectual ...

UK-based Yasa has revealed a potentially game-changing in-wheel electric motor. Based on its record-breaking tiny axial flux motor, the new drive unit prototype can provide over 1,000 hp per wheel.

AEMO has released the 2025 Transition Plan for System Security outlining key points and the investments required to maintain system security in the National Electricity Market (NEM) over the next ...

If you’ve ever driven on a Texas highway, you’ve probably noticed most people aren’t going the exact speed limit. Cars zip by in the fast lane, and before long, you might find yourself speeding up ...

Abbott is getting into cancer testing with its $21 billion acquisition Exact Sciences, the maker of the game-changing colorectal cancer test Cologuard. Abbott markets well-known diagnostics for ...

Abbott made a takeover offer for Exact Sciences. The two companies want to team up to combat cancer. Under the terms of the deal, Exact Sciences' stockholders would receive $105 per share in cash. The ...

Abbott announced on Thursday, Nov. 20 it plans to buy Exact Sciences, a Madison-based maker of cancer screening and diagnostic tests, in a deal valued at an estimated $23 billion, including debt. The ...

Abbot Laboratory has announced a deal to acquire Madison-based Exact Sciences for approximately $21 billion. Exact Sciences, known for its Cologuard cancer screening test, was founded in 1995 and ...

Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy. Abbott Laboratories $21 billion deal to acquire cancer test maker Exact ...